恆生科指續跌1.9% 擬發CDR獲上交所受理聯想集團(00992.HK)逆漲一成
納指上週五反彈0.8%結束五連跌。不過,本港恆生科技指數三連跌,今天長週末假後復市低見5,936,現報5,986,續挫近1.9%。
30只恆科成份股普遍下跌,屢尋底阿裏巴巴(09988.HK)、快手(01024.HK)、中芯(00981.HK)、金山軟件(03888.HK)、京東集團(09618.HK)、網易(09999.HK)、美團(03690.HK)、舜宇(02382.HK)及閱文(00772.HK)跌逾2%-5%,前者低見138.1元屢創上市新低,後三者沽壓最大分別報237元、196.2元及56.25元。
平安好醫生(01833.HK)、京東健康(06618.HK)、衆安在線(06060.HK)及阿裏健康(00241.HK)跌逾2%-4%,後者最傷報10.68元,回吐4.6%。
然而,聯想集團(00992.HK)建議發行不超過13.38億股普通股的中國存託憑證(CDR)及在上海科創板上市申請,已獲上交所受理。該股今早逆市高見9.32元創近四個月高,現報9.2元,回升9.9%,成交急增至7,060萬股。
金蝶(00268.HK)、ASM(00522.HK)及攜程(09961.HK)也升逾1%-3.5%,後兩者最強分別報87.85元及243.4元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.